Skip to content
healthcare.dev

Terazosin

NDC 50090-2623, Terazosin Hydrochloride, capsule, from A-S Medication Solutions.

Product NDC
50090-2623
Status
Listed
Labeler
A-S Medication Solutions
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA075317
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50090-2623 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TERAZOSIN HYDROCHLORIDE2 mg/1

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
50090-2623-05009026230030 CAPSULE in 1 BOTTLE (50090-2623-0)
50090-2623-15009026230190 CAPSULE in 1 BOTTLE (50090-2623-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/83bf40fa-6ae1-4811-8dc1-e8c0bcd63d78

Use it

Look up 50090-2623 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50090-2623 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50090-2623. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.